Sopharma posted 13% y/y rise in top line for FY2017
The leading pharma producer Sopharma posted 13% y/y growth of its revenues for FY2017, the Company announced in its regular monthly bulletin. Overall for 2017, the group increased its domestic sales by 3% and its export advanced by 21% y/y as Russian and Ukrainian markets began to recover.
bg